Amy Welsh
Corporate Officer/Principal chez AGILE THERAPEUTICS, INC.
Fortune : 5 400 $ au 30/04/2024
Profil
Amy Welsh is currently the Chief Commercial Officer at Agile Therapeutics, Inc. She previously worked as the Vice President-Marketing at Antares Pharma, Inc. from 2017 to 2020.
Ms. Welsh completed her undergraduate degree at LaSalle University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AGILE THERAPEUTICS, INC.
0,20% | 28/06/2023 | 13 500 ( 0,20% ) | 5 400 $ | 30/04/2024 |
Postes actifs de Amy Welsh
| Sociétés | Poste | Début |
|---|---|---|
| AGILE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2022 |
Anciens postes connus de Amy Welsh
| Sociétés | Poste | Fin |
|---|---|---|
| ANTARES PHARMA, INC. | Sales & Marketing | 01/05/2020 |
Formation de Amy Welsh
| LaSalle University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
